Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 2
1973 4
1974 1
1975 3
1976 4
1977 6
1978 1
1979 4
1980 2
1981 6
1982 4
1983 2
1986 5
1987 4
1988 3
1991 2
1995 3
1996 1
1997 6
1998 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Controlled clinical trial of cannabidiol in Huntington's disease.
Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, Kennedy K, Schram K. Consroe P, et al. Pharmacol Biochem Behav. 1991 Nov;40(3):701-8. doi: 10.1016/0091-3057(91)90386-g. Pharmacol Biochem Behav. 1991. PMID: 1839644 Clinical Trial.
Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
Consroe P, Jones B, Laird H. Consroe P, et al. Ann N Y Acad Sci. 1976;281:198-211. doi: 10.1111/j.1749-6632.1976.tb27931.x. Ann N Y Acad Sci. 1976. PMID: 798523 Review. No abstract available.
Marihuana and epilepsy.
Martin P, Consroe P. Martin P, et al. Among authors: consroe p. Science. 1977 Sep 23;197(4310):1302. doi: 10.1126/science.197.4310.1302. Science. 1977. PMID: 17781985 No abstract available.
Stereochemical requirements for cannabimimetic activity.
Mechoulam R, Lander N, Srebnik M, Breuer A, Segal M, Feigenbaum JJ, Jarbe TU, Consroe P. Mechoulam R, et al. Among authors: consroe p. NIDA Res Monogr. 1987;79:15-30. NIDA Res Monogr. 1987. PMID: 3125475 Review.
Audiogenic seizure susceptible rats.
Consroe P, Picchioni A, Chin L. Consroe P, et al. Fed Proc. 1979 Sep;38(10):2411-6. Fed Proc. 1979. PMID: 383516 Review. No abstract available.
Specific pharmacological management of acute toxicity due to "psychedelic" drugs.
Consroe PF. Consroe PF. Ariz Med. 1972 Dec;29(12):920-5. Ariz Med. 1972. PMID: 4581781 Review. No abstract available.
A review of recent advances in cannabinoid research and the 1994 International Symposium on Cannabis and the Cannabinoids.
Musty RE, Reggio P, Consroe P. Musty RE, et al. Among authors: consroe p. Life Sci. 1995;56(23-24):1933-40. doi: 10.1016/0024-3205(95)00173-4. Life Sci. 1995. PMID: 7776816 Review. No abstract available.
Brain cannabinoid systems as targets for the therapy of neurological disorders.
Consroe P. Consroe P. Neurobiol Dis. 1998 Dec;5(6 Pt B):534-51. doi: 10.1006/nbdi.1998.0220. Neurobiol Dis. 1998. PMID: 9974182 Review.
Treatment of acute hallucinogenic drug toxicity: specific pharmacological intervention.
Consroe PF. Consroe PF. Bull Natl Clgh Poison Control Cent. 1973 Jan-Feb:1-7. Bull Natl Clgh Poison Control Cent. 1973. PMID: 4571809 Review. No abstract available.
Enantiomeric cannabinoids: stereospecificity of psychotropic activity.
Mechoulam R, Feigenbaum JJ, Lander N, Segal M, Järbe TU, Hiltunen AJ, Consroe P. Mechoulam R, et al. Among authors: consroe p. Experientia. 1988 Sep 15;44(9):762-4. doi: 10.1007/BF01959156. Experientia. 1988. PMID: 3416993
66 results
Jump to page